Association between age and survival in a cohort of Brazilian patients with operable breast cancer;Associação entre idade e sobrevida em uma coorte de pacientes brasileiras com câncer de mama operável;Asociación entre edad y supervivencia en una cohorte de pacientes brasileñas con cáncer de mama operable

Cadernos de Saude Publica

Volumn 31, Issue 8, 2015, Pages 1732-1742

  Balabram, Débora ^a   Turra, Cassio M ^a   Gobbi, Helenice ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Age factors; Breast neoplasms; Ethnicity and health; Neoplasm staging

Indexed keywords

ADULT; AGE; AGED; BRAZIL; BREAST NEOPLASMS; CANCER STAGING; COHORT ANALYSIS; EPIDEMIOLOGY; FEMALE; HUMAN; MIDDLE AGED; MORTALITY; PATHOLOGY; RETROSPECTIVE STUDY; SURVIVAL ANALYSIS;

ADULT; AGE FACTORS; AGED; BRAZIL; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84941551374     PISSN: 0102311X     EISSN: 16784464     Source Type: Journal    
DOI: 10.1590/0102-311X00114214     Document Type: Article

References (42)

1. Instituto Nacional de Câncer José Alencar Gomes da Silva. INCA e Ministério da Saúde apresentam estimativas de câncer para 2014. http://www2. inca.gov.br/wps/wcm/connect/agencianoticias/ site/home/noticias/2013/inca_ministerio_saude_ apresentam_estimativas_cancer_2014 (accessed on 20/Jul/2014).
2. Turner N, Zafarana E, Becheri D, Mottino G, Biganzoli L. Breast cancer in the elderly: which lessons have we learned? Future Oncol 2013; 9:1871-81.
3. Instituto Nacional de Câncer José Alencar Gomes da Silva. Atlas de mortalidade por câncer. http://mor talidade.inca.gov.br/Mortalidade/ (accessed on 24/Jun/2012).
4. Instituto Brasileiro de Geografia e Estatística. Atlas do Censo Demográfico 2010. http://www.ibge.gov. br/home/geociencias/geografia/atlas.shtm?c=5 (accessed on 15/Sep/2014).
5. Gennari R, Curigliano G, Rotmensz N, Robertson C, Colleoni M, Zurrida S, et al. Breast carcinoma in elderly women: features of disease presentation, choice of local and systemic treatments compared with younger postmenopasual patients. Cancer 2004; 101:1302-10.
6. Schonberg MA, Marcantonio ER, Ngo L, Li D, Silliman RA, McCarthy EP. Causes of death and rl.ive survival of older women after a breast cancer diagnosis. J Clin Oncol 2011; 29:1570-7.
7. Dutra MC, Rezende MA, de Andrade VP, Soares FA, Ribeiro M V, de Paula EC, et al. Imunofenótipo e evolução de câncer de mama: comparação entre mulheres muito jovens e mulheres na pós-menopausa. Rev Bras Ginecol Obstet 2009; 31:54-60.
8. Schonberg MA, Marcantonio ER, Li D, Silliman RA, Ngo L, McCarthy EP. Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 2010; 28:2038-45.
9. Yood MU, Owusu C, Buist DSM, Geiger AM, Field TS, Thwin SS, et al. Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 2008; 206:66-75.
10. Thomas GA, Leonard RC. How age affects the biology of breast cancer. Clin Oncol (R Coll Radiol) 2009; 21:81-5.
11. Colzani E, Liljegren A, Johansson ALV, Adolfsson J, Hellborg H, Hall PFL, et al. Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristics. J Clin Oncol 2011; 29:4014-21.
12. Balabram D, Turra CM, Gobbi H. Survival of patients with operable breast cancer (Stages I-III) at a Brazilian public hospital-a closer look into cause-specific mortality. BMC Cancer 2013; 13:434.
13. Beadle BM, Woodward WA, Buchholz TA. The impact of age on outcome in early-stage breast cancer. Semin Radiat Oncol 2011; 21:26-34.
14. Jatoi I, Anderson WF, Rosenberg PS. Qualitative age-interactions in breast cancer: a tale of two diseases? Am J Clin Oncol 2008; 31:504-6.
15. Berglund A, Wigertz A, Adolfsson J, Ahlgren J, Fornander T, Wärnberg F, et al. Impact of comorbidity on management and mortality in women diagnosed with breast cancer. Breast Cancer Res Treat 2012; 135:281-9.
16. Jørgensen TL, Hallas J, Friis S, Herrstedt J. Comorbidity in elderly cancer patients in relation to overall and cancer-specific mortality. Br J Cancer 2012; 106:1353-60.
17. th Ed. New York: Springer; 2009.
18. thEd. Lyon: IARC Press; 2012.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-83.
20. Peto R, Davies C, Godwin J, Gray R, Pan HC, Clarke M, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet 2012; 379:432-44.
21. Darby S, McGale P, Correa C, Taylor C, Arriagada R, Clarke M, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet 2011; 378:1707-16.
22. Dignam JJ, Huang L, Ries L, Reichman M, Mariotto A, Feuer E. Estimating breast cancer-specific and other-cause mortality in clinical trial and population-based cancer registry cohorts. Cancer 2009; 115:5272-83.
23. Howlader N, Ries LAG, Mariotto AB, Reichman ME, Ruhl J, Cronin KA. Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst 2010; 102:1584-98.
24. Camargo Jr. KR, Coeli CM. Reclink: aplicativo para o relacionamento de bases de dados, implementando o método probabilistic record linkage. Cad Saúde Pública 2000; 16:439-47.
25. World Health Organization. International Classification of Diseases (ICD). http://www.who.int/ classifications/icd/en/ (accessed on 03/Sep/2011).
26. Biganzoli L, Wildiers H, Oakman C, Marotti L, Loibl S, Kunkler I, et al. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA). Lancet Oncol 2012; 13:e148-60.
27. Ring A, Reed M, Leonard R, Kunkler I, Muss H, Wildiers H, et al. The treatment of early breast cancer in women over the age of 70. Br J Cancer 2011; 105:189-93.
28. Instituto Nacional de Câncer José Alencar Gomes da Silva. SISMAMA-informação para o avanço das ações de controle do câncer de mama no Brasil. http://bvsms.saude.gov.br/bvs/publicacoes/ inca/Sismama.pdf (accessed on 31/Mar/2013).
29. National Cancer Institute. SEER Stat Fact Sheets: breast. http://seer.cancer.gov/statfacts/html/ breast.html (accessed on 01/Apr/2014).
30. Liedke PER, Finkelstein DM, Szymonifka J, Barrios CH, Chavarri-Guerra Y, Bines J, et al. Outcomes of breast cancer in Brazil related to health care coverage: a retrospective cohort study. Cancer Epidemiol Biomarkers Prev 2014; 23:126-33.
31. Alves C, Silva MSD, Pinto LM, Toralles MBP, Tavares-Neto J. Definition and use of the variable "race" by medical students in Salvador, Brazil. São Paulo Med J 2010; 128:206-10.
32. Pena SDJ, Di Pietro G, Fuchshuber-Moraes M, Genro JP, Hutz MH, Kehdy FSG, et al. The genomic ancestry of individuals from different geographical regions of Brazil is more uniform than expected. PLoS One 2011; 6:e17063.
33. Pena SDJ. Razões para banir o conceito de raça da medicina brasileira. Hist Ciênc Saúde-Manguinhos 2005; 12:321-46.
34. Smith EC, Ziogas A, Anton-Culver H. Delay in surgical treatment and survival after breast cancer diagnosis in young women by race/ethnicity. JAMA Surg 2013; 148:516-23.
35. Chor D. Health inequalities in Brazil: race matters. Cad Saúde Pública 2013; 29:1272-5.
36. Chor D, Lima CRA. Aspectos epidemiológicos das desigualdades raciais em saúde no Brasil. Cad Saúde Pública 2005; 21:1586-94.
37. Haller B, Schmidt G, Ulm K. Applying competing risks regression models: an overview. Lifetime Data Anal 2013; 19:33-58.
38. Riihimäki M, Thomsen H, Brandt A, Sundquist J, Hemminki K. Death causes in breast cancer patients. Ann Oncol 2012; 23:604-10.
39. Du XL, Fox EE, Lai D. Competing causes of death for women with breast cancer and change over time from 1975 to 2003. Am J Clin Oncol 2008; 31:105-16.
40. Cho H, Mariotto AB, Mann BS, Klabunde CN, Feuer EJ. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence. Am J Epidemiol 2013; 178:339-49.
41. Oliveira EXG, Melo ECP, Pinheiro RS, Noronha CP, Carvalho MS. Acesso à assistência oncológica: mapeamento dos fluxos origem-destino das internações e dos atendimentos ambulatoriais. O caso do câncer de mama. Cad Saúde Pública 2011; 27:317-26.
42. Silber JH, Rosenbaum PR, Clark AS, Giantonio BJ, Ross RN, Teng Y, et al. Characteristics associated with differences in survival among black and white women with breast cancer. JAMA 2013; 310:389-97.